X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Europe Cancer Biomarkers Companies

This report lists the top Europe Cancer Biomarkers companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Europe Cancer Biomarkers industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Europe Cancer Biomarkers Top Companies

  1. Abbott Laboratories

  2. Roche

  3. Illumina

  4. Thermo Fisher Scientific

  5. bioMérieux

*Disclaimer: Top companies sorted in no particular order

Europe Cancer Biomarkers Market Major Players

Europe Cancer Biomarkers Market Concentration

Europe Cancer Biomarkers  Market Concentration

Europe Cancer Biomarkers Company List

                      • Illumina Inc.

                      • Creative Diagnostics

                      • Abbott Laboratories Inc.

                      • Agilent Technologies

                      • Biomerieux SA

                      • Quest Diagnostics

                      • F. Hoffmann-La Roche Ltd

                      • Hologic Inc.

                      • Thermo Fisher Scientific Inc.

                      • 23andMe

                      • Ambry Genetics (Konica Minolta Inc.)

                      • Johnson & Johnson Services Inc.

                      • Epigenomics AG

                      • Qiagen AG

                      • Bio-Rad Laboratories Inc.

                      • PerkinElmer Inc.


                  Specific to Europe Cancer Biomarkers Market
                  Need More Details On Market Players And Competitors?
                  Download PDF

                  Europe Cancer Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)